Literature DB >> 24964701

Budget impact analysis.

Pattara Leelahavarong.   

Abstract

A budget impact analysis (BIA) is used to assess whether the adoption of a new health technology is affordable, given the resource and budget constraints of the context. Increasingly, BIAs are coming to be viewed as an important-if not essential-part of health technology assessment (HTA). BIA data is often examined in conjunction with cost-effectiveness analysis (CEA) data to help inform decisions makers when developing reimbursement policies within the resource constraints of their health care system. This article presents a review of existing BIA guidelines from around the world and makes some initial recommendations for the development of Thai BIA guidelines, as part of the newly-developed Economic Evaluation guidelines for Thailand. Initial recommendations include guidelines on appropriate analytic framework design, study design, perspective, scenarios for comparison, target population, costing and resource use, uncertainty analysis, and discounting.

Mesh:

Year:  2014        PMID: 24964701

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  6 in total

1.  Systematic Literature Review of Guidelines on Budget Impact Analysis for Health Technology Assessment.

Authors:  Yashika Chugh; Maria De Francesco; Shankar Prinja
Journal:  Appl Health Econ Health Policy       Date:  2021-05-06       Impact factor: 2.561

Review 2.  The French National Authority for Health (HAS) Guidelines for Conducting Budget Impact Analyses (BIA).

Authors:  Salah Ghabri; Erwan Autin; Anne-Isabelle Poullié; Jean Michel Josselin
Journal:  Pharmacoeconomics       Date:  2018-04       Impact factor: 4.981

3.  Economic Evaluation of Human Rotavirus Vaccine in Thailand.

Authors:  Surasak Saokaew; Wasana Prasitsuebsai; Gyneth Lourdes Bibera; Kirati Kengkla; Xu-Hao Zhang; Kyu-Bin Oh; Christa Lee
Journal:  Infect Dis Ther       Date:  2019-06-13

Review 4.  A methodological review of national and transnational pharmaceutical budget impact analysis guidelines for new drug submissions.

Authors:  Naghmeh Foroutan; Jean-Eric Tarride; Feng Xie; Mitchell Levine
Journal:  Clinicoecon Outcomes Res       Date:  2018-11-26

5.  Is the Scope of Costs Considered in Budget Impact Analyses for Anticancer Drugs Rational? A Systematic Review and Comparative Study.

Authors:  Yue Ma; Yuxin Li; Aixia Ma; Hongchao Li
Journal:  Front Public Health       Date:  2021-11-05

6.  An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.

Authors:  Kittiphong Thiboonboon; Pattara Leelahavarong; Duangrurdee Wattanasirichaigoon; Nithiwat Vatanavicharn; Pornswan Wasant; Vorasuk Shotelersuk; Suthipong Pangkanon; Chulaluck Kuptanon; Sumonta Chaisomchit; Yot Teerawattananon
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.